(Reuters) – Alnylam Pharmaceuticals said on Thursday its experimental therapy for hypertension met the main goal in a mid-stage study.
(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)
(Reuters) – Alnylam Pharmaceuticals said on Thursday its experimental therapy for hypertension met the main goal in a mid-stage study.
(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)